These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33331279)

  • 21. FKB327: An Adalimumab Biosimilar.
    Al-Salama ZT
    BioDrugs; 2019 Feb; 33(1):113-116. PubMed ID: 30712241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methyl aminolaevulinate photodynamic therapy in practice: treatment protocol.
    Foley P
    Australas J Dermatol; 2005 Feb; 46 Suppl 3():S14; discussion S23-5. PubMed ID: 15859304
    [No Abstract]   [Full Text] [Related]  

  • 23. Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab.
    Moltó A; Mateo L; Lloveras N; Olivé A; Minguez S
    Joint Bone Spine; 2010 May; 77(3):271-3. PubMed ID: 20378385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical aspects of methyl aminolaevulinate photodynamic therapy.
    Foley P
    Australas J Dermatol; 2005 Feb; 46 Suppl 3():S12-3; discussion S23-5. PubMed ID: 15859303
    [No Abstract]   [Full Text] [Related]  

  • 25. Coxiella burnetii infection (Q fever) in rheumatoid arthritis patients with and without anti-TNFα therapy.
    Schoffelen T; Kampschreur LM; van Roeden SE; Wever PC; den Broeder AA; Nabuurs-Franssen MH; Sprong T; Joosten LA; van Riel PL; Oosterheert JJ; van Deuren M; Creemers MC
    Ann Rheum Dis; 2014 Jul; 73(7):1436-8. PubMed ID: 24794150
    [No Abstract]   [Full Text] [Related]  

  • 26. Are cutaneous vessels one of the targets of resurfacing with photodynamic therapy?
    Redondo P
    J Cosmet Dermatol; 2008 Jun; 7(2):149-50. PubMed ID: 18482021
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical efficacy of methyl aminolaevulinate photodynamic therapy in basal cell carcinoma and solar keratosis.
    Foley P
    Australas J Dermatol; 2005 Feb; 46 Suppl 3():S8-10; discussion S23-5. PubMed ID: 15859301
    [No Abstract]   [Full Text] [Related]  

  • 28. A decade of data discloses the window is still not clear.
    Cohen M
    J Rheumatol; 2014 Jan; 41(1):1-2. PubMed ID: 24382923
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors.
    Martínez-Feito A; Plasencia-Rodríguez C; Navarro-Compán V; Hernández-Breijo B; González MÁ; Monjo I; Nuño L; Nozal P; Pascual-Salcedo D; Balsa A
    Clin Rheumatol; 2019 Mar; 38(3):949-954. PubMed ID: 30402698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methyl aminolaevulinate photodynamic therapy for Bowen's disease: a practical option?
    Morton CA
    Australas J Dermatol; 2005 Feb; 46 Suppl 3():S21-2; discussion S23-5. PubMed ID: 15859305
    [No Abstract]   [Full Text] [Related]  

  • 31. Short-contact, low-dose methyl aminolaevulinate photodynamic therapy for acne vulgaris.
    Dessinioti C; Masouri S; Drakaki E; Katsambas A; Antoniou C
    Br J Dermatol; 2016 Jul; 175(1):215. PubMed ID: 26854014
    [No Abstract]   [Full Text] [Related]  

  • 32. Topical photodynamic therapy for Bowen's disease.
    Morton CA
    Australas J Dermatol; 2005 Feb; 46 Suppl 3():S11; discussion S23-5. PubMed ID: 15859302
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term follow-up assessment of daylight photodynamic therapy with methyl aminolevulinate in patients with actinic keratosis.
    Fai D; Fai C; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2017 Jun; 152(3):318-319. PubMed ID: 28409583
    [No Abstract]   [Full Text] [Related]  

  • 34. Kaposi's disease in a patient on adalimumab for rheumatoid arthritis.
    Bret J; Hernandez J; Aquilina C; Zabraniecki L; Fournie B
    Joint Bone Spine; 2009 Dec; 76(6):721-2. PubMed ID: 19945327
    [No Abstract]   [Full Text] [Related]  

  • 35. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
    Asahina A; Ishii N; Tohma S
    J Dermatol; 2012 Feb; 39(2):199-201. PubMed ID: 21463364
    [No Abstract]   [Full Text] [Related]  

  • 36. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
    Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
    Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
    [No Abstract]   [Full Text] [Related]  

  • 37. Systemic nocardiosis in a case of rheumatoid arthritis treated with tumor necrosis factor blockers.
    Wendling D; Murad M; Mathieu S; Berger E; Rumbach L
    J Rheumatol; 2008 Mar; 35(3):539-42. PubMed ID: 18322977
    [No Abstract]   [Full Text] [Related]  

  • 38. Adalimumab biosimilar in rheumatoid arthritis: a total-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.
    Mengato D; Messori A
    Clin Exp Rheumatol; 2018; 36(6):1118. PubMed ID: 29600941
    [No Abstract]   [Full Text] [Related]  

  • 39. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study.
    Kellner C; Bauriedl S; Hollstein S; Reinhold U
    Br J Dermatol; 2015 Apr; 172(4):1146-8. PubMed ID: 25244353
    [No Abstract]   [Full Text] [Related]  

  • 40. Can photodynamic therapy reverse the signs of photoageing and field cancerization?
    Morton CA
    Br J Dermatol; 2012 Jul; 167(1):2. PubMed ID: 22738409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.